SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-011580
Filing Date
2019-12-18
Accepted
2019-12-18 16:23:07
Documents
5
Period of Report
2019-12-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 81668
2 EX-3.1 ex-3d1.htm EX-3.1 9367
3 EX-10.1 ex-10d1.htm EX-10.1 32720
4 EX-10.2 ex-10d2.htm EX-10.2 287340
5 EX-14.1 ex-14d1.htm EX-14.1 89501
  Complete submission text file 0001558370-19-011580.txt   502216
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 191292750
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences